Clinical trial · Observational

Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities

Cancer Prevention and Treatment Demonstration for Hispanic Medicare Eligible Beneficiaries - CMS

NCT00453661CI-TRIAL-00047995completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The goal of this behavioral research study is to improve the use of cancer prevention services, increase early detection, and treatment of cancer. A secondary outcome of this demonstration project proposes that a structured patient navigator (PN) will reduce the cost of Medicare services.

Conditions

Conditions (5)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Breast Cancer	Malignant Breast Neoplasm	CURATED_EXACT	0.92
Cervical Cancer	Malignant Cervical Neoplasm	CURATED_EXACT	0.92
Colorectal Cancer	Malignant Colorectal Neoplasm	CURATED_BROADER	0.80
Lung Cancer	Malignant Lung Neoplasm	CURATED_EXACT	0.92
Prostate Cancer	Malignant Prostate Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (2)

Intervention	Type	Mapped drug	Match
Patient Navigator (PN)	Behavioral	—	UNRESOLVED
Questionnaire	Behavioral	—	UNRESOLVED

Design

Arms and outcomes

Arms (2)

label
Intervention Group
description
Patient Navigator (PN) + Educational Materials + Annual Questionnaires
interventionNames
1. Behavioral: Questionnaire
2. Behavioral: Patient Navigator (PN)
label
Comparison Group
description
Educational Materials + Exit Questionnaire
interventionNames
1. Behavioral: Questionnaire

Primary outcomes (1)

measure
Screening Rates
timeFrame
4 Years

Secondary outcomes (1)

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 40 Years

Show eligibility criteria text

Inclusion Criteria:

1. All participants must have Medicare Part A and Part B
2. All participants must be Latino / Hispanic American
3. All participants must be at least 40 years of age
4. All Cancer Screening Group participants must be a Medicare-eligible beneficiary from Region 6 (Central Gulf Coast) as defined by Texas Department of State Health Services.
5. All Cancer Treatment Group participants must have been diagnosed with breast, cervix, prostate, colorectal, and/or lung cancer within the past 5 years.
6. All Cancer Treatment Group participants must be a Medicare-eligible beneficiary from Texas.

Exclusion Criteria:

1. All participants must not be enrolled in a managed care plan (also called an HMO, Medicare + Choice, or Medicare Advantage)
2. All participants must not be enrolled in hospice
3. All Cancer Screening Group participants must not have been diagnosed with cancer within the last 5 years.
4. All Cancer Treatment Group participants must not be a Medicare-eligible beneficiary outside of Region 6 (Central Gulf Coast) unless treated at MD Anderson.

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Mar 1, 2007
Primary completion: Sep 28, 2020
Completion: Sep 28, 2020
First posted: Mar 29, 2007
Last update posted: Oct 29, 2020
Enrollment: 2,472 (actual)
Lead sponsor: M.D. Anderson Cancer Center OTHER
Collaborators: Centers for Medicare and Medicaid Services
Keywords: Breast Cancer, Cervical Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Cancer Prevention, Treatment Demonstration for Ethnic and Racial Minorities, Centers for Medicare and Medicaid Services, CMS, Hispanic American, Cancer Screening Assessment, Annual Questionnaire, Patient Navigator, Educational Materials

Data updated 22 days agoSource updated Oct 29, 2020source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
United States	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.